TCL Archive Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors. September 5, 2008
TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992
TCL Archive NCI Reorganization: DEC Epidemiology Stays In Place, DCPC To Build Its Own – No Decision Yet Enters, Other DCPC Program – CIS Moved To OCC, ICIC ut Of OIA June 24, 1988